9-25 | Urgent need to scale up newer tools available today to save lives; and develop a fast, safe and simple cure for TB As global leaders gather for the first-ever United Nations tuberculosis (TB) Summit in New York this week, Médecins Sans Frontières (MSF)/Doctors Without Borders called on governments to save more lives by scaling up TB testing and treatment today, and make real commitments to develop more effective and easier-to-use tools to defeat TB tomorrow. New global TB figures released last week by
7-23 | As the annual global HIV/AIDS conference gets underway in Amsterdam, Médecins Sans Frontières (MSF) called out ViiV Healthcare—a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline plus Japan’s Shionogi—for preventing children with HIV from getting child-appropriate formulations of a critical HIV medicine, dolutegravir. The World Health Organization (WHO) now recommends dolutegravir as a preferred treatment option for adults and for children from four weeks to ten years of age, to replace pediatric treatments containing sub-optima
7-20 | RCEP trade deal could cut medicines lifeline for people in developing countries As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed door negotiations, public health experts and the international medical humanitarian organization - Médecins Sans Frontières (MSF) warn that inclusion of any harmful intellectual property provisions in the agreement could have a severely negative impact on access to affordable generic medicines.
6-19 | Affordable generic versions from China could save millions of people’s lives Médecins Sans Frontières (MSF) today filed a legal patent challenge at China’s State Intellectual Property Office (SIPO), requesting the invalidation of the patent granted to US pharmaceutical corporation Gilead Sciences for the oral hepatitis C medicine velpatasvir.
3-28 | by Joanne Liu (the international president of Médecins Sans Frontières.) and Paual Farmer (The co-founder of Partners in Health, Professor of Global Health and Social Medicine at Harvard Medical School, and Chief of the Division of Global Health Equity at Brigham and Women’s Hospital.) Though TB can strike anyone, it disproportionately afflicts marginalized and vulnerable populations in places like refugee camps, slums, and prisons.